Nicotine lozenge compositions

Details for Australian Patent Application No. 2009243065 (hide)

Owner GlaxoSmithKline LLC

Inventors Chen, Li-Lan

Agent Davies Collison Cave

Pub. Number AU-A-2009243065

PCT Pub. Number WO2009/134947

Priority 61/049,515 01.05.08 US

Filing date 30 April 2009

Wipo publication date 5 November 2009

International Classifications

A61K 47/00 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 31/715 (2006.01) - Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages

Event Publications

2 December 2010 PCT application entered the National Phase

  PCT publication WO2009/134947 Priority application(s): WO2009/134947

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009243066-Methods and kits for the treatment of inflammatory bowel disorder conditions

2009243064-Fuel compositions comprising an amorphane or a stereoisomer thereof and methods of making and using same